Atlas Venture Associates XI, L.P. — SEC Form 4 filings
SEC reporting owner CIK 1780068. 6 Form 4 filings on record with FilingPulse; latest filed 2025-02-10.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2024-01-16 to 2025-02-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 60,000 shares, $1,080,000 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 35 legs across 5 filings — 1,824,014 shares, $42,838,216 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 7.
- Largest priced transaction: sale of 272,923 shares @ $24.38 ($6,653,863) in Dyne Therapeutics, Inc., filed 2024-02-28.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Dyne Therapeutics, Inc. (DYN) | 10% owner | 3 | — | 29 legs · 1,818,779 sh · $42,833,976 | — |
| Sionna Therapeutics, Inc. (SION) | 10% owner | 1 | 1 leg · 60,000 sh · $1,080,000 | — | 7 |
| Xilio Therapeutics, Inc. (XLO) | 10% owner | 2 | — | 6 legs · 5,235 sh · $4,240 | — |
Form 4 filings — Atlas Venture Associates XI, L.P.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-02-10 | 4 | Sionna Therapeutics, Inc. (SION) jointly with Atlas Venture Fund XI, L.P., Atlas Venture Associates XI, LLC, Atlas Venture Opportunity Fund II, L.P., Atlas Venture Associates Opportunity II, LP, Atlas Venture Associates Opportunity II, LLC | Conversion (C): 2,886,293 · Conversion (C): 747,727 · Purchase (P): 60,000 @ $18 · Conversion (C): 1,051,051 (derivative) @ $0 · Conversion (C): 1,806,317 (derivative) @ $0 · Conversion (C): 1,298,332 (derivative) @ $0 · +2 more | EDGAR |
| 2024-02-28 | 4 | Dyne Therapeutics, Inc. (DYN) jointly with Atlas Venture Fund XI, L.P., Atlas Venture Associates XI, LLC, Atlas Venture Opportunity Fund I, L.P., Atlas Venture Associates Opportunity I, L.P., Atlas Venture Associates Opportunity I, LLC, Atlas Venture Opportunity Fund II, L.P., Atlas Venture Associates Opportunity II, LP, Atlas Venture Associates Opportunity II, LLC | Sale (S): 136,312 @ $23.59 · Sale (S): 64,783 @ $23.98 · Sale (S): 20,205 @ $23.59 · Sale (S): 9,603 @ $23.98 · Sale (S): 11,736 @ $23.59 · Sale (S): 5,580 @ $23.98 · +12 more | EDGAR |
| 2024-02-23 | 4 | Dyne Therapeutics, Inc. (DYN) jointly with Atlas Venture Fund XI, L.P., Atlas Venture Associates XI, LLC, Atlas Venture Opportunity Fund I, L.P., Atlas Venture Associates Opportunity I, L.P., Atlas Venture Associates Opportunity I, LLC, Atlas Venture Opportunity Fund II, L.P., Atlas Venture Associates Opportunity II, LP, Atlas Venture Associates Opportunity II, LLC | Sale (S): 149,337 @ $22.44 · Sale (S): 35,164 @ $23.14 · Sale (S): 119,360 @ $22.66 · Sale (S): 159,542 @ $22.70 · Sale (S): 23,648 @ $22.70 · Sale (S): 13,738 @ $22.70 | EDGAR |
| 2024-02-20 | 4 | Dyne Therapeutics, Inc. (DYN) jointly with Atlas Venture Fund XI, L.P., Atlas Venture Associates XI, LLC | Sale (S): 175,793 @ $23.88 · Sale (S): 2,113 @ $24.45 · Sale (S): 162,707 @ $23.14 · Sale (S): 166,029 @ $22.71 · Sale (S): 3,510 @ $23.40 | EDGAR |
| 2024-02-09 | 4 | Xilio Therapeutics, Inc. (XLO) jointly with Atlas Venture Fund XI, L.P., Atlas Venture Associates XI, LLC, Atlas Venture Opportunity Fund I, L.P., Atlas Venture Associates Opportunity I, L.P., Atlas Venture Associates Opportunity I, LLC | Sale (S): 733 @ $0.64 · Sale (S): 267 @ $0.64 | EDGAR |
| 2024-01-16 | 4 | Xilio Therapeutics, Inc. (XLO) jointly with Atlas Venture Fund XI, L.P., Atlas Venture Associates XI, LLC, Atlas Venture Opportunity Fund I, L.P., Atlas Venture Associates Opportunity I, L.P., Atlas Venture Associates Opportunity I, LLC | Sale (S): 1,566 @ $0.87 · Sale (S): 569 @ $0.87 · Sale (S): 1,540 @ $0.83 · Sale (S): 560 @ $0.83 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1780068 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →